Literature DB >> 17637949

Clinical onset of celiac disease after an episode of Campylobacter jejuni enteritis.

E F Verdu1, M Mauro, J Bourgeois, D Armstrong.   

Abstract

The present report describes a young woman with no previous gastrointestinal complaints who was initially diagnosed with postinfective irritable bowel syndrome (IBS) after a confirmed case of Campylobacter jejuni enteritis. However, because of persistent diarrhea, new-onset bloating and the development of iron and vitamin deficiencies, serological markers for celiac disease (CD) were evaluated. A positive tissue transglutaminase immunoglobulin A antibody test and repeat endoscopy with duodenal biopsy showing a Marsh IIIa lesion confirmed the diagnosis of CD. Infectious gastroenteritis is a well-established risk factor for the development of IBS, and there is recent evidence that it could play a role in the initiation and exacerbation of inflammatory bowel disease. The present case suggests that the clinical expression of CD can be unmasked by an acute gastrointestinal infection and supports the hypothesis that environmental factors other than gliadin may play a role in the clinical onset of CD in a genetically susceptible host. The increasing availability of serological testing and upper endoscopy has led to increasingly frequent diagnoses of CD and recognition that it may mimic IBS. The present case findings suggest that CD should be considered in the differential diagnosis of persistent IBS-like symptoms after an episode of infectious gastroenteritis.

Entities:  

Mesh:

Year:  2007        PMID: 17637949      PMCID: PMC2657967          DOI: 10.1155/2007/169591

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  11 in total

1.  Increased prevalence of Helicobacter pylori infection in patients with celiac disease.

Authors:  P C Konturek; E Karczewska; W Dieterich; E G Hahn; D Schuppan
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

2.  Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study.

Authors:  L A Rodríguez; A Ruigómez
Journal:  BMJ       Date:  1999-02-27

Review 3.  Intestinal permeation and gastrointestinal disease.

Authors:  Mark T DeMeo; Ece A Mutlu; Ali Keshavarzian; Mary C Tobin
Journal:  J Clin Gastroenterol       Date:  2002-04       Impact factor: 3.062

4.  Adenovirus 12 E1A gene detection by polymerase chain reaction in both the normal and coeliac duodenum.

Authors:  M Lawler; P Humphries; C O'Farrelly; H Hoey; O Sheils; M Jeffers; D S O'Briain; D Kelleher
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

5.  Characteristics of adult celiac disease in the USA: results of a national survey.

Authors:  S N Stavropoulos; S G Panagi; S L Goldstein; D J Mcmahon; H Absan; A I Neugut
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

6.  Celiac sprue: another autoimmune syndrome associated with hepatitis C.

Authors:  K D Fine; F Ogunji; Y Saloum; S Beharry; J Crippin; J Weinstein
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

7.  Persistent diarrhea in the returning traveler: think beyond persistent infection.

Authors:  Brian R Landzberg; Bradley A Connor
Journal:  Scand J Gastroenterol       Date:  2005-01       Impact factor: 2.423

8.  Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease.

Authors:  Luis Alberto García Rodríguez; Ana Ruigómez; Julián Panés
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

Review 9.  Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum.

Authors:  A Fasano; C Catassi
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

Review 10.  Association of celiac disease with connective tissue diseases and autoimmune diseases of the digestive tract.

Authors:  Nicola Bizzaro; Danilo Villalta; Elio Tonutti; Marilina Tampoia; Danila Bassetti; Renato Tozzoli
Journal:  Autoimmun Rev       Date:  2003-10       Impact factor: 9.754

View more
  17 in total

Review 1.  Salmonella, Shigella, and yersinia.

Authors:  John P Dekker; Karen M Frank
Journal:  Clin Lab Med       Date:  2015-04-02       Impact factor: 1.935

Review 2.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 3.  Celiac disease: prevalence, diagnosis, pathogenesis and treatment.

Authors:  Naiyana Gujral; Hugh J Freeman; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

Review 4.  Celiac disease: should we care about microbes?

Authors:  Alberto Caminero; Elena F Verdu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-06-12       Impact factor: 4.052

Review 5.  The clinical importance of emerging Campylobacter species.

Authors:  Si Ming Man
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-25       Impact factor: 46.802

6.  Pathogen-specific risk of celiac disease following bacterial causes of foodborne illness: a retrospective cohort study.

Authors:  Mark S Riddle; Joseph A Murray; Brooks D Cash; Mark Pimentel; Chad K Porter
Journal:  Dig Dis Sci       Date:  2013-06-29       Impact factor: 3.199

Review 7.  The chronic gastrointestinal consequences associated with campylobacter.

Authors:  Mark S Riddle; Ramiro L Gutierrez; Elena F Verdu; Chad K Porter
Journal:  Curr Gastroenterol Rep       Date:  2012-10

8.  The incidence and risk of celiac disease in a healthy US adult population.

Authors:  Mark S Riddle; Joseph A Murray; Chad K Porter
Journal:  Am J Gastroenterol       Date:  2012-05-15       Impact factor: 10.864

9.  Treatment with the Probiotic Product Aviguard® Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice.

Authors:  Markus M Heimesaat; Dennis Weschka; Soraya Mousavi; Stefan Bereswill
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

Review 10.  Interplay Between Gluten, HLA, Innate and Adaptive Immunity Orchestrates the Development of Coeliac Disease.

Authors:  Jordan Voisine; Valérie Abadie
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.